Opening book details…
About this Medicine article
Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1 by Petzold, Tobias ;Thienel, Manuela ;Dannenberg, Lisa ;Mourikis, Philipp ;Helten, Carolin ;Ayhan, Aysel ;M’Pembele, René ;Achilles, Alina ;Trojovky, Kajetan ;Konsek, Daniel ;Zhang, Zhe ;Regenauer, Ron ;Pircher, Joachim ;Ehrlich, Andreas ;Lüsebrink, Enzo ;Nicolai, Leo ;Stocker, Thomas J. ;Brandl, Richard ;Röschenthaler, Franz ;Strecker, Jan ;Saleh, Inas ;Spannagl, Michael ;Mayr, Christoph H. ;Schiller, Herbert B. ;Jung, Christian ;Gerdes, Norbert ;Hoffmann, Till ;Levkau, Bodo ;Hohlfeld, Thomas ;Zeus, Tobias ;Schulz, Christian ;Kelm, Malte ;Polzin, Amin is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Petzold, Tobias ;Thienel, Manuela ;Dannenberg, Lisa ;Mourikis, Philipp ;Helten, Carolin ;Ayhan, Aysel ;M’Pembele, René ;Achilles, Alina ;Trojovky, Kajetan ;Konsek, Daniel ;Zhang, Zhe ;Regenauer, Ron ;Pircher, Joachim ;Ehrlich, Andreas ;Lüsebrink, Enzo ;Nicolai, Leo ;Stocker, Thomas J. ;Brandl, Richard ;Röschenthaler, Franz ;Strecker, Jan ;Saleh, Inas ;Spannagl, Michael ;Mayr, Christoph H. ;Schiller, Herbert B. ;Jung, Christian ;Gerdes, Norbert ;Hoffmann, Till ;Levkau, Bodo ;Hohlfeld, Thomas ;Zeus, Tobias ;Schulz, Christian ;Kelm, Malte ;Polzin, Amin
- Publisher
- Lippincott Williams and Wilkins; Ovid Technologies Wolters Kluwer -American Heart Association; Lippincott Williams & Wilkins Ltd.; Ovid Technologies (Wolters Kluwer Health) (ISSN 0009-7330)
- Published
- 2020
- Field
- Medicine (Health Sciences)